Compounds > droxidopa
Page last updated: 2024-08-26

droxidopa and Basal Ganglia Diseases

droxidopa has been researched along with Basal Ganglia Diseases in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Goto, Y; Konagaya, M; Konishi, T; Matsuoka, Y1
Imai, H; Komiya, T; Narabayashi, H; Usui, S1

Other Studies

2 other study(ies) available for droxidopa and Basal Ganglia Diseases

ArticleYear
[Malignant syndrome in multiple system atrophy].
    No to shinkei = Brain and nerve, 1997, Volume: 49, Issue:6

    Topics: Adult; Aged; Antidepressive Agents; Antiparkinson Agents; Atrophy; Basal Ganglia Diseases; Corpus Striatum; Droxidopa; Female; Humans; Male; Middle Aged; Neuroleptic Malignant Syndrome; Spinocerebellar Degenerations; Substantia Nigra

1997
[Metrizamide encephalopathy in a child with hydrocephalus--effects of L-threo-DOPS on persistent disturbance of consciousness and L-dopa on extrapyramidal symptoms].
    No to shinkei = Brain and nerve, 1988, Volume: 40, Issue:11

    Topics: Basal Ganglia Diseases; Brain; Brain Diseases; Child; Cognition Disorders; Consciousness Disorders; Droxidopa; Electroencephalography; Extravasation of Diagnostic and Therapeutic Materials; Female; Humans; Hydrocephalus; Levodopa; Metrizamide; Serine; Tomography, X-Ray Computed

1988